We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-0.67%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$784M
AUM Growth
-$507M
Cap. Flow
-$491M
Cap. Flow %
-62.66%
Top 10 Hldgs %
20.36%
Holding
914
New
32
Increased
9
Reduced
351
Closed
300

Top Buys

Rank Stock Value
1
IBRX icon
ImmunityBio
IBRX
+$41.8M
2
AMRS
Amyris Inc.
AMRS
+$40.6M
3
KPTI icon
Karyopharm Therapeutics
KPTI
+$5.79M
4
RTB
RTB Digital
RTB
+$4.04M
5
XFOR icon
X4 Pharmaceuticals
XFOR
+$3.76M

Top Sells

Rank Stock Value
1
MBAC
M3-Brigade Acquisition II Corp.
MBAC
+$18.9M
2
LGV
Longview Acquisition Corp. II
LGV
+$17.3M
3
GAPA
G&P Acquisition Corp.
GAPA
+$16M
4
KAHC
KKR Acquisition Holdings I Corp.
KAHC
+$13M
5
CFIV
CF Acquisition Corp. IV Class A common stock
CFIV
+$12.8M

Sector Composition

Rank Sector Weight
1 Financials 63.76%
2 Healthcare 12.95%
3 Technology 8.47%
4 Industrials 4.61%
5 Materials 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ERAS icon
151
Erasca
ERAS
$6.15B
$1.62M 0.21%
+376,716
New +$2.55M
FZT
152
DELISTED
FAST Acquisition Corp. II
FZT
$1.6M 0.2%
159,764
+29,525
+23% +$292K
KCGI
153
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$1.59M 0.2%
155,759
-13,568
-8% -$137K
FNVT
154
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$1.59M 0.2%
154,740
-25
-0% -$254
CIIG
155
DELISTED
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
$1.57M 0.2%
153,926
– –
TGR
156
DELISTED
Kimbell Tiger Acquisition Corporation
TGR
$1.54M 0.2%
150,000
– –
GDST
157
DELISTED
Goldenstone Acquisition Limited Common Stock
GDST
$1.53M 0.2%
150,000
– –
SYRS
158
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.53M 0.19%
425,500
– –
NRAC
159
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$1.52M 0.19%
150,085
-24,882
-14% -$249K
FTEV
160
DELISTED
FinTech Evolution Acquisition Group
FTEV
$1.51M 0.19%
149,784
-18,807
-11% -$188K
FRLA
161
DELISTED
Fortune Rise Acquisition Corporation Class A Common Stock
FRLA
$1.48M 0.19%
143,655
-6,839
-5% -$70K
RZLT icon
162
Rezolute
RZLT
$453M
$1.47M 0.19%
709,015
-145,967
-17% -$273K
SCOB
163
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
$1.45M 0.19%
143,422
-10,609
-7% -$106K
OTEC
164
DELISTED
OceanTech Acquisitions I Corp. Class A Common Stock
OTEC
$1.42M 0.18%
135,000
-259,483
-66% -$2.67M
VMCA
165
DELISTED
Valuence Merger Corp. I Class A Ordinary Shares
VMCA
$1.4M 0.18%
134,223
-15,777
-11% -$162K
AEAE
166
DELISTED
AltEnergy Acquisition Corp
AEAE
$1.37M 0.17%
133,628
– –
MVLA
167
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$1.33M 0.17%
131,694
-2,000
-1% -$20K
COCH icon
168
Envoy Medical
COCH
$49.5M
$1.3M 0.17%
128,241
-24,798
-16% -$247K
ACAH
169
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$1.28M 0.16%
127,622
-8,384
-6% -$83.2K
EMCG
170
DELISTED
Embrace Change Acquisition Corp
EMCG
$1.22M 0.16%
+118,500
New +$1.2M
GLST
171
DELISTED
Global Star Acquisition, Inc. Class A Common Stock
GLST
$1.21M 0.15%
+120,000
New +$1.21M
DGNU
172
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$1.21M 0.15%
122,756
+56,447
+85% +$556K
CCVI
173
DELISTED
Churchill Capital Corp VI
CCVI
$1.19M 0.15%
118,757
+13,430
+13% +$133K
SHAP
174
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
$1.16M 0.15%
113,896
-15
-0% -$152
IQMD
175
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
$1.16M 0.15%
112,453
-7,432
-6% -$75.5K
5 6
7
8 9

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q4 2022 Portfolio in Review

As of Q4 2022, CVI Holdings held 914 positions worth $784M, down 39% from $1.29B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

CVI Holdings withdrew a net $491M in Q4 2022, closing 300 positions and reducing 351 holdings. Its most notable exit was M3-Brigade Acquisition II Corp., an estimated $18.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 64% of assets, down from 69% a quarter earlier, followed by Healthcare and Technology.

Against the trend, CVI Holdings opened a new position in ImmunityBio worth $38.6M.

  • CVI Holdings's largest Q4 2022 buy was ImmunityBio: 7,609,166 shares worth $38.6M.
  • CVI Holdings added most to Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares in Q4 2022, an estimated $556K increase.
  • CVI Holdings's biggest Q4 2022 reduction was Banzai International, cutting an estimated $4.51M.
  • CVI Holdings fully exited M3-Brigade Acquisition II Corp. in Q4 2022, selling an estimated $18.9M.
  • CVI Holdings's ten largest holdings make up 20% of its $784M portfolio in Q4 2022.
  • CVI Holdings opened 32 new positions and closed 300 in Q4 2022.
  • CVI Holdings's portfolio value fell 39% quarter-over-quarter to $784M.

Based on CVI Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.